Abstract:Objective The ALKBH2 gene is highly expressed in urothelial tumors,and RNA interference( RNAi) technology cannot downregulate the target genes stably. The aim of this study was to construct and identify a lentiviral vector for RNA interference of human ALKBH2( ABH2). Methods The coding region of the ABH2 gene sequences were analyzed for a single-stranded oligo design and synthesis. PCR was performed for splicing reaction of synthetic oligo,which was synthesized into the pcDNA3. 1( +) vector and transformed into the competent cell DH5α. An expression vector pcDNA3. 1( +) / ABH2 was constructed after sequencing and identifying the gene sequence of the recombinant clones. According to the target gene sequence,three pairs of shRNA were designed and synthesized and built into the U6 carrier. The shRNA vectors were co-transfected with expression vectors into the HEK-293 cell line,and the optimal interference sequence was screened by QPCR. The screened shRNA-571,as the most effective interference sequence,was constructed into the lentiviral vector,pL / shRNA / F carrier. The 293T cells were co-transfected with the constructed lentiviral interference vectors and packaging plasmids,the viruses were packed,the virus stock was collected and concentrated by ultracentrifugation,and the titer of the viruses was determined. The LV-shRNA-57 was co-transfected with the over-expression vector pcDNA3. 1( +) /ABH2 into ACHN renal carcinoma,and the optimal interference sequence was screened by QPCR. Results Gene sequencing proved that the recombinant clone gene sequence was correct,and the lentiviral vector was successfully constructed. The titer of the concentrated virus was 1. 1 × 108TU / mL in the viral supernatant of 293T cells collected at 48 hours after co-transfection. The relative expression of ABH2 mRNA was significantly reduced in the siRNA-571 group after RNAi as compared with that in the control group( 0. 078 ± 0. 006 vs 0. 785 ± 0. 082,P 0. 01). The interference efficiency of the lentiviral vector PL / shRNA / F-ALKBH2-571 in the target gene ABH2 was 92. 2%. Conclusion A lentiviral RNAi expression vector targeting the ABH2 gene was successfully constructed and identified.

Construction and verification of a lentivector for beta arrestin 2 short hairpin RNA

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

BC047440 silencing in HepG2 cells mediated by lentiviral vector

Construction and appraisal of recombinant adeno-associated virus vector for expressing shRNA targeting CIP2A mRNA

Construction and identification of siRNA expression vectors of adaptor protein 2 gene

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Target-specific inhibition of Akt2 in non-small cell lung cancer A549 cell line mediated by lentivirus vector

Interference of shRNA onAkt2in human HepG2.2.15 cell mediated by lentivirus

Construction and Identification of a Lentiviral RNAi Expression Vector Targeting the ALKBH2 Gene

Construction and Sequence Verification of an Expression Vector for shRNA Specific for HnRNP A2/B1

Construction of Lentiviral Vector of RNA Interference of PKCY Gene

Construction and Identification of Lentiviral Vector of RNA Interference of CRBP-1 Gene

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Construction of Lentiviral Vector Containing Sirna Sequence of Siglec-1 and Verification of Inhibition Efficiency

Construction and Sequencing of lentiviral Vector of Short Hairpin RNA of Rat CRBP-1 Gene

Construction and Verification of Lentiviral Vectors Targeting for Human BRCA1 Gene

Construction and Identification of a Recombinant Lentiviral Vector Encoding Shrna Targeting Rat CBP Gene

Construction and identification of adenoviral vectors expressing shRNA targeting CDK1 gene]

Construction and Preliminary Function Assay of a Lentivirus-Medi ated mTOR Knock-Down Hepatoma Cell Line HepG2

Construction and Identification of PPARγ Shrna Lentiviral Vector in Rats